Mutations in KRAS are the most frequent genetic changes, followed by mutations in tumor suppressors TP53, SMAD4 and CDKN2A [15] that cause changes in multiple molecular pathways, resulting in cancer development. The gene discussed is KRAS; the disease is cancer.